Oncotelic Therapeutics, Inc. earnings releases OTLC

Annual Quarterly

Oncotelic Therapeutics, Inc. last reported quarterly results on Nov 24, 2021, for the quarter ended Sep 30, 2021. It usually reports 30–55 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 30–55 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
Nov 24, 2021 55 days after quarter end	— ended Sep 30, 2021	—	—	—
Nov 10, 2015 41 days after quarter end	— ended Sep 30, 2015	—	—	—
Aug 4, 2015 35 days after quarter end	— ended Jun 30, 2015	—	—	—
Apr 30, 2015 30 days after quarter end	— ended Mar 31, 2015	—	—	—
Nov 12, 2014 43 days after quarter end	— ended Sep 30, 2014	—	—	—
Aug 5, 2014 36 days after quarter end	— ended Jun 30, 2014	—	—	—
May 6, 2014 36 days after quarter end	— ended Mar 31, 2014	—	—	—
Jan 13, 2014 13 days after quarter end	— ended Dec 31, 2013	—	—	—

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: OTLC (OTC)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Aguora Hills, CA
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 908259
Former names: MATEON THERAPEUTICS INC (until Mar 26, 2021); OXIGENE INC (until Jun 3, 2016)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.